Financial Summary (All financials)
In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
Revenues | 2,214,730.8 | 892,434.2 | 782,428.8 | 674,124.5 | 595,348.5 | 508,359.8 | 424,170.3 | 367,664.1 |
Revenue growth | 148.2% | 14.1% | 16.1% | 13.2% | 17.1% | 19.8% | 15.4% | 23.0% |
Cost of goods sold | 202,156.9 | 165,287.7 | 143,755.9 | 130,506.9 | 104,652.6 | 98,483.7 | 92,663.0 | 85,932.9 |
Gross profit | 2,012,573.9 | 727,146.5 | 638,672.9 | 543,617.6 | 490,695.9 | 409,876.1 | 331,507.3 | 281,731.2 |
Gross margin | 90.9% | 81.5% | 81.6% | 80.6% | 82.4% | 80.6% | 78.2% | 76.6% |
Selling, general and administrative | | | | | | | | |
General and administrative | 202,932.4 | 154,931.4 | 149,223.0 | 133,439.4 | 108,960.4 | 93,272.9 | 74,637.7 | 64,607.3 |
EBITA | 33,916.7 | 554,013.6 | 467,589.1 | 381,109.6 | 341,877.8 | 283,316.9 | 231,251.2 | 169,802.4 |
EBITA margin | 1.5% | 62.1% | 59.8% | 56.5% | 57.4% | 55.7% | 54.5% | 46.2% |
Amortization of intangibles | | | | | 1.0 | 1.0 | 3.0 | 7.0 |
EBIT | 33,916.7 | 554,013.6 | 467,589.1 | 381,109.6 | 341,876.8 | 283,315.9 | 231,248.2 | 169,795.4 |
EBIT margin | 1.5% | 62.1% | 59.8% | 56.5% | 57.4% | 55.7% | 54.5% | 46.2% |
Pre-tax income | 8,058.9 | 519,162.2 | 439,826.5 | 365,844.0 | 339,959.0 | 277,106.4 | 219,965.5 | 185,586.8 |
Income taxes | 672,554.0 | 132,559.2 | 113,820.1 | 105,480.0 | 119,393.5 | 98,272.5 | 79,224.9 | 67,536.9 |
Tax rate | 8345.5% | 25.5% | 25.9% | 28.8% | 35.1% | 35.5% | 36.0% | 36.4% |
Net income | 2,002,343.6 | 386,000.4 | 325,977.1 | 260,269.9 | 220,103.8 | 178,514.9 | 140,529.8 | 117,915.3 |
Net margin | 90.4% | 43.3% | 41.7% | 38.6% | 37.0% | 35.1% | 33.1% | 32.1% |
|
Diluted EPS | $358.38 | $69.38 | $59.02 | $47.27 | $40.66 | $34.15 | $54.57 | $46.33 |
Shares outstanding (diluted) | 5,587.2 | 5,563.5 | 5,523.5 | 5,505.8 | 5,413.7 | 5,227.9 | 2,575.4 | 2,545.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|